Prezcobix label
Interaction Color Code
Clinical Bottom Line
Do not coadminister: Potential for increased dihydroergotamine levels
Drug 1
Drug 2
Clinical Effects
Potential for increased risk of dihydroergotamine adverse effects (e.g. peripheral vasospasm, ischemia)
Management
Contraindicated. Use alternative agents.
Alternative Agents
5-HT agonists ("triptans")
Import ID
926
